Tags |
|
|
Links |
|
|
Wiki Articles - Bullish Development In India
This past weekend there was a big article in the Financial Times on the development of "tier two" cities in India. As the middle class in India booms due to huge employm
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ent opportunities in software, technology and medical careers, a huge educated elite is being created. These Indians are demanding top quality western style goods and s
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ervices, which historically have been available only in the major metropolitan centers or in top resort areas.
Indian style goods are in abundance everywhere, but the n
Indian style goods are in abundance everywhere, but the n
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
veau riche Indians want western style haircuts, apparel, transportation, shopping facilities, restaurants, etc. Much of India still lives simply, in the traditional way
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
that they have lived for centuries. I personally find this way of life lovely and inviting, but many modern Indians feel it is old fashioned.
To respond to this deman
To respond to this deman
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
d, and to encourage foreign investment, the Indian government is focusing on building infrastructure in the next tier cities. This is very positive for two reasons.
1.
1.
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
The current infrastructure in India is highly problematic and desperately needs improvement.
2. These second tier cities with a few million residents have lower land an
2. These second tier cities with a few million residents have lower land an
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
d labor costs. This will encourage more investment by Indian companies in these areas, as well as encourage more direct foreign investment.
Foreign investment has been
Foreign investment has been
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
an area where India has greatly lagged China. In short, China has encouraged foreign capital while India has discouraged it. The very fact that the Indian government
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
s encouraging the development of infrastructure in these tier 2 cities is a very positive sign and will stimulate India's continued growth in decades to come.
These art
These art
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
icles are for informational purposes only and are not intended to be a solicitation, offering or recommendation of any security. Guild Investment Management does not re
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
present that the securities, products, or services discussed in this web site are suitable or appropriate for all investors. Any market analysis constitutes an opinion
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
that may not be correct. Readers must make their own independent investment decisions.
The information in this article is not intended for distribution to, or use by,
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation, or which would subject Guild Investment Manage
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ment to any registration requirement within such jurisdiction or country.
Any opinions expressed herein, are subject to change without notice. In addition, there are m
Any opinions expressed herein, are subject to change without notice. In addition, there are m
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ny market, currency, economic, political, business, technological and other risks that are beyond our control. We make reasonable efforts to provide accurate content in
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
these articles; however, some content and some of the assumptions, formulas, algorithms and other data that impact the content may be inaccurate, outdated, or otherwise
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
inappropriate. In addition, we may have conflicts of interest with respect to any investments mentioned. Our principals and our clients may hold positions in investme
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ts mentioned on the site or we may take positions contrary to investments mentioned.
Guild’s current and past market commentaries are protected by copyright. Apart fro
Guild’s current and past market commentaries are protected by copyright. Apart fro
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
m any use permitted under the Copyright Act, you must not copy, frame, modify, transmit or distribute the market commentaries, without seeking the prior consent of Guild
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.wiki-articles.org.ua/article/101512/wiki-articles-Bullish-Development-In-India.html">Bullish Development In India</a>
BB link (for phorums):
[url=http://www.wiki-articles.org.ua/article/101512/wiki-articles-Bullish-Development-In-India.html]Bullish Development In India[/url]
Related Articles:
Personal Attributes and Aptitude Required for Pharmaceutical Sales Reps
Why Audio – In Internet Marketing?
Bookmark it:
|